Form 4 Tracker
David Malcom Rodman

Chief Medical Officer · 12 filings · Latest: May 11, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
Rodman David MalcomNov 6, 2024
Proposed Sale
$15.0325,482$383.1K
MLYS
Rodman David MalcomNov 11, 2024
Proposed Sale
$15.005,026$75.4K

← Previous

Page 4 of 4